CTNNB1 S45F Mutation Predicts Poor Efficacy of Meloxicam Treatment for Desmoid Tumors: A Pilot Study
出版年份 2014 全文链接
标题
CTNNB1 S45F Mutation Predicts Poor Efficacy of Meloxicam Treatment for Desmoid Tumors: A Pilot Study
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 5, Pages e96391
出版商
Public Library of Science (PLoS)
发表日期
2014-05-02
DOI
10.1371/journal.pone.0096391
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ‘Difficult to diagnose’ desmoid tumours: a potential role forCTNNB1mutational analysis
- (2015) Chiara Colombo et al. HISTOPATHOLOGY
- Nuclear expression of β-catenin predicts the efficacy of meloxicam treatment for patients with sporadic desmoid tumors
- (2014) Shunsuke Hamada et al. TUMOR BIOLOGY
- Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group
- (2013) A. Gronchi et al. ANNALS OF ONCOLOGY
- CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence
- (2013) Chiara Colombo et al. CANCER
- -Catenin Mutation Status and Outcomes in Sporadic Desmoid Tumors
- (2013) J. T. Mullen et al. ONCOLOGIST
- The treatment of desmoid tumors: a stepwise clinical approach
- (2012) S. Bonvalot et al. ANNALS OF ONCOLOGY
- β-Catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis
- (2012) Sebastian Huss et al. HISTOPATHOLOGY
- Is It Possible to Identify Clinically Useful Prognostic Groups for Patients With Desmoid Tumors?
- (2012) Yoshihiro Nishida et al. JOURNAL OF CLINICAL ONCOLOGY
- CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics
- (2012) Sophie Le Guellec et al. MODERN PATHOLOGY
- Transition of Treatment for Patients with Extra-Abdominal Desmoid Tumors: Nagoya University Modality
- (2012) Yoshihiro Nishida et al. Cancers
- Update on desmoid tumors
- (2011) C. Escobar et al. ANNALS OF ONCOLOGY
- High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management
- (2010) J Dômont et al. BRITISH JOURNAL OF CANCER
- Primary or recurring extra-abdominal desmoid fibromatosis: Assessment of treatment by observation only
- (2010) O. Barbier et al. Orthopaedics & Traumatology-Surgery & Research
- Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment
- (2009) Marco Fiore et al. ANNALS OF SURGICAL ONCOLOGY
- Cyclooxygenase-2 Overexpression Predicts Poor Survival in Patients with High-grade Extremity Osteosarcoma: A Pilot Study
- (2009) Hiroshi Urakawa et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Efficiency evaluation of a DNA extraction and purification protocol on archival formalin-fixed and paraffin-embedded tissue
- (2009) A. Farrugia et al. FORENSIC SCIENCE INTERNATIONAL
- Successful Treatment With Meloxicam, a Cyclooxygenase-2 Inhibitor, of Patients With Extra-Abdominal Desmoid Tumors: A Pilot Study
- (2009) Yoshihiro Nishida et al. JOURNAL OF CLINICAL ONCOLOGY
- Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors
- (2008) Alexander J.F. Lazar et al. AMERICAN JOURNAL OF PATHOLOGY
- Surgical treatment for local control of extremity and trunk desmoid tumors
- (2008) Yoji Shido et al. ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started